Last reviewed · How we verify
NCT03099915: AERO
Asthma Attack in the Emergency Department : Reasons Of This Attendance
trial testing completion of self-reported questionnaires in Asthma Attack in 182 participants. Completed in 31 December 2019.
30 March 2019
Quick facts
| Lead sponsor | Olivier CHASSANY |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 182 |
| Start date | 17 March 2017 |
| Primary completion | 30 March 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 2 locations across France |
Drugs / interventions tested
- completion of self-reported questionnaires
Conditions studied
- Asthma Attack — all drugs for Asthma Attack →
- Emergency Medicine — all drugs for Emergency Medicine →
Sponsor
Olivier CHASSANY
Who can join
18 and older, any sex, with Asthma Attack or Emergency Medicine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: Identify modifiable factors that may affect asthma control and the use of emergency room to define customized interventions for the management of asthma prior to emergency room. Emergency department attendance is always a sign of poor balance or control of asthma. In spite of a decrease in the number of deaths that has been halved in 20 years and hospitalization due to asthmatic disease, the use of emergency center for this disease has not decreased. We now know that the passage through emergencies and hospitalization for aggravation of asthma is in itself a factor of mortality. Acting on the determinants of poor balance or control of asthma is essential to further reduce the mortality and morbidity of asthma.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Assessment of Predictor Factors Associated with Multiple Emergency Department Attendance with Asthma Attack: A Qualitative and Multicentric Prospective Observational Study.
Vaittinada Ayar P, Taillé C, Vaittinada Ayar P, Gay M, et al · · 2022 · cited 2× · PMID 35283637 · DOI 10.2147/jaa.s337072
Verify or expand the search:
- PubMed search for NCT03099915
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of completion of self-reported questionnaires
Trials testing the same drug.
- NCT03002584 — International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ) · completed
Other recruiting trials for Asthma Attack
Currently open trials in the same condition.
- NCT07129616 — Remote Monitoring of Asthma in Children and Young People · recruiting
- NCT07052942 — Individualizing Treatment for Asthma in Primary Care (Full Study) · Phase 4 · recruiting
- NCT06734793 — Wearable Electronic Breath Sound Sensing Device · recruiting
- NCT06377345 — Remote Patient Monitoring Solution for Chronic Respiratory Disease Management · NA · recruiting
- NCT06137040 — Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation · EARLY_PHASE1 · recruiting
Other Olivier CHASSANY trials
Trials by the same sponsor.
- NCT05532085 — Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03099915 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Olivier CHASSANY
- Last refreshed: 27 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03099915.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing